At-home sleep tests are devices used to screen for sleep apnea. But getting one isn’t as easy as adding it to your cart. You need to talk to your doctor. Taylor Leamey wrote about all things wellness ...

Acurable, a U.K.-based medical device company, announced it raised €11 million ($10.8 million) in a Series A funding round led by Kibo Ventures. Mundi Ventures, Comprador Holdings and Kindred Capital ...

SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced its home ...

NORTH PHILADELPHIA (WPVI) -- Few things are as precious as a good night's sleep. People who snore, gasp, or stop breathing may fear overnight testing in a sleep lab. There's been a revolution in ...

(RTTNews) - ResMed Inc.(RMD), announced Thursday that its NightOwl home sleep apnea test or HSAT is now available across the United States, providing a simple and effective at-home diagnostic solution ...

TAMPA, Fla.--(BUSINESS WIRE)--Sleep technology company REMware™ has signed an agreement with Side Health, a national chronic care management company, to provide sleep apnea testing services to meet ...

Both at-home sleep tests and smartwatches gather data on your sleep. Here's how to decide which one is right for you. Taylor Leamey wrote about all things wellness for CNET, specializing in mental ...

The AcuPebble, developed by Imperial spinout Acurable, promises easier access to a diagnosis and savings for the health service. A wearable medical device that tests for the breathing disorder ...

Precision Pulmonary Diagnostics will offer portable monitor testing of sleep apnea in commercial drivers. The portable monitors provide an alternative to in-lab overnight sleep testing. Instead, ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Getty Images Sleep ...

Sleep apnea is prevalent in patients with HF, adding a high-risk comorbidity that can persist even after heart transplant, say the authors of a new study. The findings highlight the important role ...